Accession Number: | 0001708138-20-000084 |
Date: | 2020-07-07 |
Issuer: | REGENERON PHARMACEUTICALS, INC. (REGN) |
Original Submission Date: |
LANDRY ROBERT E
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-07-07 | M | 10,000 | a | $555.67 | 33,973 | direct | ||
COMMON STOCK | 2020-07-07 | F | 9,321 | d | $640.88 | 24,652 | direct | ||
COMMON STOCK | 2020-07-07 | M | 2,500 | a | $399.66 | 27,152 | direct | ||
COMMON STOCK | 2020-07-07 | F | 2,019 | d | $640.88 | 25,133 | direct | ||
COMMON STOCK | 2020-07-08 | S | 24 | d | $634.14 | 25,109 | direct | ||
COMMON STOCK | 2020-07-08 | S | 585 | d | $636.50 | 24,524 | direct | ||
COMMON STOCK | 2020-07-08 | S | 40 | d | $637.40 | 24,484 | direct | ||
COMMON STOCK | 2020-07-08 | S | 45 | d | $638.99 | 24,439 | direct | ||
COMMON STOCK | 2020-07-08 | S | 80 | d | $639.88 | 24,359 | direct | ||
COMMON STOCK | 2020-07-08 | S | 43 | d | $640.32 | 24,316 | direct | ||
COMMON STOCK | 2020-07-08 | S | 48 | d | $642.93 | 24,268 | direct | ||
COMMON STOCK | 2020-07-08 | S | 104 | d | $643.84 | 24,164 | direct | ||
COMMON STOCK | 2020-07-08 | S | 57 | d | $645.99 | 24,107 | direct | ||
COMMON STOCK | 2020-07-08 | S | 37 | d | $646.18 | 24,070 | direct | ||
COMMON STOCK | 2020-07-08 | S | 94 | d | $648.54 | 23,976 | direct | ||
COMMON STOCK | 2020-07-08 | S | 3 | d | $650.41 | 23,973 | direct | ||
COMMON STOCK | 2020-07-07 | 0 | $0.00 | 200 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 399.66 | 2020-07-07 | deemed execution date | M | 2,500 (d) | 2024-12-16 | common stock 2,500 | $399.66 | 31,500 | direct | ||
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 555.67 | 2020-07-07 | deemed execution date | M | 10,000 (d) | 2025-12-16 | common stock 10,000 | $555.67 | 10,000 | direct |
ID | footnote |
---|---|
f1 | disposition/acquisition made pursuant to a plan intended to comply with rule 10b5-1(c). |
f2 | represents volume-weighted average price of sales of 585 shares of company stock on july 8, 2020 at prices ranging from $636.22 to $636.62. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 8, 2020 at each separate price. |
f3 | represents volume-weighted average price of sales of 104 shares of company stock on july 8, 2020 at prices ranging from $643.81 to $643.86. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 8, 2020 at each separate price. |
f4 | represents volume-weighted average price of sales of 94 shares of company stock on july 8, 2020 at prices ranging from $648.23 to $648.84. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 8, 2020 at each separate price. |
f5 | the stock option award vests in four equal annual installments, commencing one year after the date of grant. |